Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
5 hedge funds and large institutions have $161K invested in Genetic Technologies Ltd. in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
19% more capital invested
Capital invested by funds: $135K → $161K (+$26K)
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$74.2K |
| 2 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$27.6K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$21.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8K |
| 3 |
Jane Street
New York
|
-$8K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $113K | +$74.2K | +1,852 | +170% |
|
|
TDC
2
Thompson Davis & Co
Richmond,
Virginia
| $27K | +$27.6K | +690 | New |
|
|
3
Ameriprise
Minneapolis,
Minnesota
| $9K | +$3.29K | +82 | +56% |
|
|
VKH
4
Virtu KCG Holdings
New York
| $8K | -$21.6K | -540 | -73% |
|
|
APU
5
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $4K | +$4.45K | +111 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$8K | -148 | Closed |
|
|
7
Jane Street
New York
| – | -$8K | -147 | Closed |
|
|
ARTA
8
A.R.T. Advisors
New York
| – | -$7K | -131 | Closed |
|
GENE Hedge Fund Activity: Q4 2014 in Review
5 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2014, worth a combined $161K — up 19% from $135K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GENE and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $74.2K. The largest seller was Virtu KCG Holdings, cutting an estimated $21.6K.
- 5 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2014, down from 6 in Q3 2014.
- Funds reported $161K of Genetic Technologies Ltd. stock for Q4 2014, up 19% quarter-over-quarter.
- 2 funds opened new Genetic Technologies Ltd. positions in Q4 2014 and 3 closed out, a net change of -1 holder.
- The largest Genetic Technologies Ltd. buyer in Q4 2014 was Renaissance Technologies, an estimated $74.2K added.
- The largest Genetic Technologies Ltd. seller in Q4 2014 was Virtu KCG Holdings, an estimated $21.6K sold.
Based on aggregated 13F filings for Q4 2014.